Department of Anesthesiology, Washington University in St. Louis, St. Louis, United States; Taylor Family Institute for Innovative Psychiatric Research, Washington University in St. Louis, St. Louis, United States
Lei Wang
Department of Anesthesiology, Washington University in St. Louis, St. Louis, United States
Allison L Germann
Department of Anesthesiology, Washington University in St. Louis, St. Louis, United States
Spencer R Pierce
Department of Anesthesiology, Washington University in St. Louis, St. Louis, United States
Thomas C Senneff
Department of Anesthesiology, Washington University in St. Louis, St. Louis, United States
Kathiresan Krishnan
Department of Developmental Biology, Washington University in St. Louis, St. Louis, United States
David E Reichert
Taylor Family Institute for Innovative Psychiatric Research, Washington University in St. Louis, St. Louis, United States; Department of Radiology, Washington University in St. Louis, St. Louis, United States
Douglas F Covey
Department of Anesthesiology, Washington University in St. Louis, St. Louis, United States; Taylor Family Institute for Innovative Psychiatric Research, Washington University in St. Louis, St. Louis, United States; Department of Developmental Biology, Washington University in St. Louis, St. Louis, United States; Department of Psychiatry, Washington University in St. Louis, St. Louis, United States
Gustav Akk
Department of Anesthesiology, Washington University in St. Louis, St. Louis, United States; Taylor Family Institute for Innovative Psychiatric Research, Washington University in St. Louis, St. Louis, United States
Department of Anesthesiology, Washington University in St. Louis, St. Louis, United States; Taylor Family Institute for Innovative Psychiatric Research, Washington University in St. Louis, St. Louis, United States; Department of Developmental Biology, Washington University in St. Louis, St. Louis, United States
This study examines how site-specific binding to three identified neurosteroid-binding sites in the α1β3 GABAA receptor (GABAAR) contributes to neurosteroid allosteric modulation. We found that the potentiating neurosteroid, allopregnanolone, but not its inhibitory 3β-epimer epi-allopregnanolone, binds to the canonical β3(+)–α1(-) intersubunit site that mediates receptor activation by neurosteroids. In contrast, both allopregnanolone and epi-allopregnanolone bind to intrasubunit sites in the β3 subunit, promoting receptor desensitization and the α1 subunit promoting effects that vary between neurosteroids. Two neurosteroid analogues with diazirine moieties replacing the 3-hydroxyl (KK148 and KK150) bind to all three sites, but do not potentiate GABAAR currents. KK148 is a desensitizing agent, whereas KK150 is devoid of allosteric activity. These compounds provide potential chemical scaffolds for neurosteroid antagonists. Collectively, these data show that differential occupancy and efficacy at three discrete neurosteroid-binding sites determine whether a neurosteroid has potentiating, inhibitory, or competitive antagonist activity on GABAARs.